Additionally, we endeavor to define the precise function of several novel adipokines, including chemerin, apelin, visfatin, adiponectin, and resistin in ovarian cancer, and prove whether their action is linked to their direct effect on cancer tissues or is the result of metabolism dysregulation in obesity-related adipose tissue. This evidence concerns the gene APLN and ovarian carcinoma.